Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.014 | 0.7 |